Debt to Equity Ratio: A measure of a company's financial leverage calculated by dividing its long-term debt by shareholders equity. Calculated as: Total Debt / Shareholders Equity
FibroBiologics Inc. (FBLG) had Debt to Equity Ratio of 0.03 for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$-4.12M |
|
-- |
|
-- |
|
$4.03M |
|
$-4.03M |
|
$-0.08M |
|
$-4.12M |
|
$-4.12M |
|
$-4.12M |
|
$-4.12M |
|
$-4.12M |
|
$-4.12M |
|
$-4.03M |
|
$-3.87M |
|
6.27M |
|
6.27M |
|
$-0.66 |
|
$-0.66 |
|
| Balance Sheet Financials | |
$5.85M |
|
$0.71M |
|
$2.08M |
|
$7.93M |
|
$2.21M |
|
-- |
|
$1.08M |
|
$3.29M |
|
$4.64M |
|
$4.64M |
|
$4.64M |
|
6.08M |
|
| Cash Flow Statement Financials | |
$-7.66M |
|
-- |
|
$6.28M |
|
$4.89M |
|
$3.52M |
|
$-1.38M |
|
$1.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.64 |
|
-- |
|
-- |
|
-- |
|
|
Debt to Equity Ratio |
0.03 |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-7.66M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-88.81% |
|
-88.81% |
|
-51.92% |
|
-88.81% |
|
$0.76 |
|
$-1.22 |
|
$-1.22 |
|